Detalles de la búsqueda
1.
Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells.
Immunity
; 33(2): 192-202, 2010 Aug 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-20674401
2.
Novel protein-based pneumococcal vaccines administered with the Th1-promoting adjuvant IC31 induce protective immunity against pneumococcal disease in neonatal mice.
Infect Immun
; 80(1): 461-8, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22025519
3.
A randomized, placebo-controlled, blinded phase 1 study investigating a novel inactivated, Vero cell-culture derived Zika virus vaccine.
J Travel Med
; 2022 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36377643
4.
Dendritic cells require STAT-1 phosphorylated at its transactivating domain for the induction of peptide-specific CTL.
J Immunol
; 183(4): 2286-93, 2009 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-19620292
5.
First in humans: a new molecularly defined vaccine shows excellent safety and strong induction of long-lived Mycobacterium tuberculosis-specific Th1-cell like responses.
Hum Vaccin
; 6(12): 1007-15, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21178394
6.
Single-shot live-attenuated chikungunya vaccine in healthy adults: a phase 1, randomised controlled trial.
Lancet Infect Dis
; 20(10): 1193-1203, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32497524
7.
Unique membrane-interacting properties of the immunostimulatory cationic peptide KLKL(5)KLK (KLK).
Cell Biol Int
; 32(11): 1449-58, 2008 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-18771740
8.
Vaccination with poly-L-arginine as immunostimulant for peptide vaccines: induction of potent and long-lasting T-cell responses against cancer antigens.
Cancer Res
; 62(5): 1477-80, 2002 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-11888923
9.
The two-component adjuvant IC31® boosts type i interferon production of human monocyte-derived dendritic cells via ligation of endosomal TLRs.
PLoS One
; 8(2): e55264, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23405128
10.
A novel HIV vaccine adjuvanted by IC31 induces robust and persistent humoral and cellular immunity.
PLoS One
; 7(7): e42163, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22848738
11.
Th17/Th1 biased immunity to the pneumococcal proteins PcsB, StkP and PsaA in adults of different age.
Vaccine
; 29(23): 3982-9, 2011 May 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-21481328
12.
Ag85B-ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infection.
Vaccine
; 29(11): 2100-9, 2011 Mar 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-21256189
13.
Ag85B-ESAT-6 adjuvanted with IC31 promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in naïve human volunteers.
Vaccine
; 28(20): 3571-81, 2010 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-20226890
14.
Type I interferons as mediators of immune adjuvants for T- and B cell-dependent acquired immunity.
Vaccine
; 27 Suppl 6: G17-20, 2009 Dec 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-20006134
15.
Identification of an indispensable role for tyrosine kinase 2 in CTL-mediated tumor surveillance.
Cancer Res
; 69(1): 203-11, 2009 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19118004
16.
The novel adjuvant IC31 strongly improves influenza vaccine-specific cellular and humoral immune responses in young adult and aged mice.
Vaccine
; 26(27-28): 3461-8, 2008 Jun 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-18495302
17.
Adult-like anti-mycobacterial T cell and in vivo dendritic cell responses following neonatal immunization with Ag85B-ESAT-6 in the IC31 adjuvant.
PLoS One
; 3(11): e3683, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-18997860
18.
Protective anti-mycobacterial T cell responses through exquisite in vivo activation of vaccine-targeted dendritic cells.
Eur J Immunol
; 38(5): 1247-56, 2008 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-18412160
19.
IC31 and IC30, novel types of vaccine adjuvant based on peptide delivery systems.
Expert Rev Vaccines
; 6(5): 741-6, 2007 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-17931154
20.
Immunogenicity and safety of a novel therapeutic hepatitis C virus (HCV) peptide vaccine: a randomized, placebo controlled trial for dose optimization in 128 healthy subjects.
Vaccine
; 24(20): 4343-53, 2006 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-16581161